MedPath

Does the use of gait analysis for decision making, improve outcomes of surgery for children with cerebral palsy?

Not Applicable
Completed
Conditions
Cerebral palsy
Nervous System Diseases
Registration Number
ISRCTN51084195
Lead Sponsor
Bloorview Kids Rehab (Canada)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

1. Diagnosis of spastic cerebral palsy
2. Age 6 to 15 years at the time of the initial assessment, either sex
3. Gross Motor Function Classification System (GMFCS) levels II or III (demonstrable independent ambulatory potential with or without orthotics/assist devices)
4. Patients have been referred for assessment and treatment of gait abnormality
5. Patients have a gait abnormality interfering with their physical function
6. Patients are candidates for orthopaedic surgery including soft tissue and/or bony procedures involving at least 2 levels, in one or both lower extremities (e.g. knee and ankle)
7. Patients must be able to undergo instrumented gait analysis testing in a motion laboratory

Exclusion Criteria

1. Presence of dystonia, athetosis, or mixed tone abnormalities
2. History of orthopaedic lower extremity procedures within the previous 2 years
3. Patients who have had previous gait laboratory analysis that has been seen by the treating surgeon
4. Patients who will be unable to return for the required follow up visits/gait analysis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Gross Motor Function Measure (GMFM-66)<br> 2. Gillette Gait (Normalcy) Index (GGI)<br> 3. Pediatric Outcomes Data Collection Instrument (PODCI)<br> 4. Functional Assessment Questionnaire (FAQ)<br> 5. Functional Mobility Scale (FMS)<br> 6. Activities Scale for Kids (ASK-performance)<br> 7. Gait Parameters: gait velocity and stride length<br><br> The final primary and secondary outcome measures will be chosen based on responsiveness and their effect sizes used to calculate sample size for the definitive trial<br>
Secondary Outcome Measures
NameTimeMethod
<br> Consistency of Surgeons' Decision Making: intra- and inter-rater reliability<br><br> The final primary and secondary outcome measures will be chosen based on responsiveness and their effect sizes used to calculate sample size for the definitive trial<br>
© Copyright 2025. All Rights Reserved by MedPath